Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3031 vs Daily G-CSF in Chemotherapy-induced Neutropenia
NCT01674855Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegteograstim in neutropenia, sponsored by Dong-A ST. Started Feb 2012; status: completed.
02
Drugs
pegteograstim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01674855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674855.